Depreciation of ENDRA Life Sciences Inc. from 31 Mar 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ENDRA Life Sciences Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2016 to 30 Sep 2025.
  • ENDRA Life Sciences Inc. Depreciation for the quarter ending 30 Sep 2025 was $10,786, a 6.2% decline year-over-year.
  • ENDRA Life Sciences Inc. annual Depreciation for 2024 was $46,489, a 62% decline from 2023.
  • ENDRA Life Sciences Inc. annual Depreciation for 2023 was $123,726, a 28% increase from 2022.
  • ENDRA Life Sciences Inc. annual Depreciation for 2022 was $96,661, a 17% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

ENDRA Life Sciences Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $10,786 -$710 -6.2% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q1 2025 $13,786 -$1,514 -9.9% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q3 2024 $11,496 -$20,562 -64% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q1 2024 $104,510 $15,300 -$19,216 -56% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $123,726 $21,887 -$10,242 -32% 01 Oct 2023 31 Dec 2023 10-K/A 07 Apr 2025 2024 FY
Q3 2023 $133,968 $32,058 +$8,265 +35% 01 Jul 2023 30 Sep 2023 10-Q/A 21 Nov 2024 2024 Q3
Q2 2023 $125,703 $35,265 +$13,564 +63% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $112,139 $34,516 +$15,478 +81% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $96,661 $32,129 +$10,868 +51% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $85,793 $23,793 -$6,030 -20% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $91,823 $21,701 -$12,028 -36% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $103,851 $19,038 -$12,387 -39% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $116,238 $21,261 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $29,823 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $33,729 -$10,285 -23% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $31,425 +$9,839 +46% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q2 2020 $44,014 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $21,586 +$1,954 +10% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q3 2019 $19,929 +$1,887 +10% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q1 2019 $19,632 +$4,293 +28% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q3 2018 $18,042 +$2,885 +19% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2019 Q3
Q1 2018 $61,130 $15,339 -$351 -2.2% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q4 2017 $61,481 $15,360 -$980 -6% 01 Oct 2017 31 Dec 2017 10-K 11 Mar 2019 2018 FY
Q3 2017 $62,461 $15,157 -$1,167 -7.1% 01 Jul 2017 30 Sep 2017 10-Q 05 Nov 2018 2018 Q3
Q2 2017 $63,628 $15,274 -$817 -5.1% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $64,445 $15,690 -$491 -3% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $64,936 $16,340 01 Oct 2016 31 Dec 2016 10-K 20 Mar 2018 2017 FY
Q3 2016 $16,324 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $16,091 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q1 2016 $16,181 01 Jan 2016 31 Mar 2016 10-Q 21 Jun 2017 2017 Q1

ENDRA Life Sciences Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $46,489 -$77,237 -62% 01 Jan 2024 31 Dec 2024 10-K/A 07 Apr 2025 2024 FY
2023 $123,726 +$27,065 +28% 01 Jan 2023 31 Dec 2023 10-K/A 07 Apr 2025 2024 FY
2022 $96,661 -$19,577 -17% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $116,238 +$16,896 +17% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $99,342 +$18,765 +23% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $80,577 +$12,261 +18% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
2018 $68,316 +$6,835 +11% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020 2019 FY
2017 $61,481 -$3,455 -5.3% 01 Jan 2017 31 Dec 2017 10-K 11 Mar 2019 2018 FY
2016 $64,936 01 Jan 2016 31 Dec 2016 10-K 20 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.